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The current status of the use of core-shell rare-earth-doped nanoparticles for 
biomedical applications is reviewed in detail. The different core-shell rare-
earth-doped nanoparticles developed so far are described and the most 
relevant examples of their application for imaging, sensing, and therapy are 
summarized. In addition, the advantages and disadvantages they present are 
discussed. Finally, a critical opinion of their potential application in real life 
biomedicine is given. 
A. Introduction
The battle against diseases is continuously bringing new 
challenges that can only be overcome if faced from a 
multidisciplinary standpoint and by taking advantage of the 
synergies between very different but complementary research 
areas such as biology, medicine, physics, chemistry, and 
mathematics. Among the current different multidisciplinary 
research lines, aimed to face the challenges posed by those 
illnesses that are the major causes of mortality (such as cancer 
or cardiovascular diseases), those focused on the development 
of new materials and techniques that would improve diagnosis 
and therapy are attracting the greatest attention. These 
research lines have three main objectives. Firstly, the 
achievement of earlier diagnosis in order to improve the 
success rate of posterior treatments. Secondly, the reduction of 
“collateral damages” and side effects caused by current therapies. Finally, the development of cost-effective diagnosis and therapy 
procedures that result in a wider distribution of health coverage and sustainable health systems. In this sense, nanotechnology is 
playing a central role as it is leading to the continuous appearance of new materials and techniques. In particular, during the last 
few years, the refinement of nanofabrication processes has led to a large variety of nanosized materials with pre-tailored 
properties and potential application as biocompatible markers, drug deliverers, and therapeutic agents. Indeed, the synergy 
between nanotechnology and medicine has led to the appearance of a new research area commonly called nanomedicine.1, 2 Its 
fundamental purpose is the use of nanoparticles (NPs, with sizes below 100 nm) as diagnostic and therapeutic agents. The reduced 
size of NPs together with adequate surface functionalization make their colloidal stability in fluids, including blood, possible.3 They 
could present a large in vivo circulation time with improved bioavailability. This allows whole body distribution of the NPs for 
imaging applications or, through specific surface chemistry, the targeting of tumours or cardiovascular lesions, for example.4, 5 
Luminescent NPs (LNPs) are one of the most popular NPs for the scientific community working in nanomedicine. They employ light 
either as trigger stimulus or as imaging signal. In comparison with other NPs used as diagnostic or therapeutic agents (such as 
magnetic NPs), LNPs have the advantage of requiring cost-effective and portable excitation sources such as near-infrared (NIR) 
laser diodes. Therefore, the use of LNPs in nanomedicine is a fast-developing research field. It was initially boosted by the use of 
visible (VIS) emitting quantum dots, dyes, and proteins6, 7. Each one of these pioneering systems has its own limitations, in most 
of the cases, regarding toxicity, long-term instability, and poor penetration into tissues. These drawbacks motivated the research 
on alternative systems such as rare-earth-doped NPs (RENPs), which were introduced almost 20 years ago.8 The advantages of 
RENPs are their low toxicity, outstanding long-term stability, narrow emission lines, and the possibility of tuning their working 
spectral ranges by adequate doping.9-11 The first RENPs developed for nanomedicine presented a very simple architecture. They 
were constituted by a core surrounded by a variable surface decoration that provided the RENPs with colloidal stability and, in 
some cases, with targeting abilities. This simple NP architecture soon evidenced some limitations. The first one was the poor 
isolation of rare-earth (RE) ions at the surface from the environment, which led to a drastic reduction in the luminescence efficiency 
(due to the increment of non-radiative processes).12 The second limitation that researchers found when working with single-core 
RENPs was the difficulty of improving their multifunctionality. First attempts to develop single-core multifunctional RENPs were 
Figure 1. (a) Publications and (b) citations of scientific papers on CS NPs (black) and 
on CS RENPs (blue) per year since 1995. Data from the Web of Science, Thomson 
Reuters. 
done by introducing several RE ions in the core.13 Unfortunately, this strategy often failed as the presence of different RE ions in 
close proximity leads to the appearance of undesirable energy transfer-assisted luminescence quenching. Thus, a new strategy 
was required to simultaneously provide RENPs with multifunctionality while keeping at minimum undesirable interactions with 
molecules in the environment. 
Core-shell (CS) engineering then emerged as a very convenient solution. CS engineering consists in the controlled growth of a 
protective shell around the original core RENP. Since the very first development of CS NPs, the scientific community realized that 
it was a powerful approach leading to new nanostructures with improved properties.14 A simple bibliographic research evidences 
this fact. Figure 1a shows the historic evolution of the number of scientific papers dealing with “core-shell nanoparticles”. As it can 
be observed, from 1996 up to now the number of published papers shows a steady growth. Most of the early published papers 
dealt with metallic (gold) NPs. In that case the interest of adopting CS structures was due to the possibility of achieving full control 
over their plasmonic resonance.15 From that moment CS engineering spreads to different fields. For instance, one of the pioneering 
works published in 1996 proposed the use of CS nanostructures for hydrogen storage.16 In 1998, it was already possible to find 
papers demonstrating the ability of CS engineering to improve the luminescent properties of LNPs, for example, how CS 
arrangement could significantly reduce photodegradation in the widely used CdSe Quantum Dots.17 This work was of special 
relevance for the expanding community working on LNPs for biomedical applications, as it demonstrated that such structures can 
be improved significantly by just adding one or two steps in their synthesis procedure. This interest was further boosted in 2005, 
when reports on the minimal toxicity that CS NPs could have in in vivo studies were published.18 This could explain the fast 
increment of citations taking place after this year. The fascination caused by CS structures affected not only the researchers 
working on metallic or semiconductor NPs, but also it influenced the scientific community working on RENPs. They directly realized 
that adopting CS structures could be a solution to the limitations impeding the real application of RENPs in biomedicine. One of 
the first works reporting on CS nanostructures containing RE ions was published in 2004 by Lu et al.19 These authors were able to 
grow an erbium and ytterbium-doped shell over a magnetic NP, resulting in a multifunctional nanostructure. At the end of the 
same year, Van Veggel´s group demonstrated the benefits of adding an inert shell to increase the brightness of RENPs.20 Some 
years later, in 2008, DiMaio et al.21 demonstrated the possibility of tailoring the spectroscopic properties of RENPs by controlling 
the energy transfer between multiple rare-earth dopants. Such control was achieved by means of an adequate combination of 
complex CS engineering and selective RE doping of the different layers.21 Just one year later, Vetrone, at Capobianco´s group, 
published a reference work introducing the “active-core/active-shell” concept and demonstrated how this can be used to 
drastically improve the brightness of upconverting (UC) RENP.14 From the analysis of the bibliographic data included in Figure 1, it 
is clear, specially looking at the time evolution of citations, that the publication of these last works constituted a milestone. The 
message sent to the scientific community was that it was worth working on the design and development of CS RENPs since this 
will be the route to eventually apply them to nanomedicine. 
At this moment, more than 10 years after the publication of these key works, the number of citations received by studies dealing 
with CS RENPs is still growing (see Figure 1b). Nevertheless, a slight deceleration in both the number of citations and number of 
publications is observed. There is no clear explanation for this fact. In our opinion, the effort over the last years have been focused 
on the synthesis of improved structures and the design and development of proof-of-concept demonstrations. Thus, the next big 
step is to bring the developed structures to the clinic and industrial applications. This will require a careful analysis of the 
achievements in the field and its potential directions, identifying the remaining challenges and their possible solutions. This review 
is aimed to contribute towards this process. The most relevant achievements regarding the potential application of CS RENPs in 
nanomedicine are herein summarized, starting with a brief description of the most commonly used routes for synthesis of CS 
RENPs (Section B), followed by their possible application in bioimaging (Section C), sensing (Section D), and therapy (Section E). 
The advantages and drawbacks of CS RENPs and a critical opinion about their applicability in clinical medicine are finally given in 
Section F. 
B. ROUTES FOR THE SYNTHESIS
Many examples can be found in the literature describing the preparation of CS RENPs and detailed and extensive reviews have been published 
on that subject.22-26 Table 1 summarizes the underlying techniques of the principles and processes described in this section for the synthesis 
of RENPs. The methods for the preparation of the shell depend strongly on the material of both the core and the shell. In principle, it is 
possible to prepare a shell of the same or different material as the core, although the growth of the shell material on the surface of the core 
NP will be easier if both materials are identical or have similar lattice parameters, as it will lead to less lattice defects. Very common is the 
preparation of NPs covered with a shell of amorphous or mesoporous silica, which is very useful not only for protecting the core materials 
from quenching effects, but also for facilitating subsequent functionalization.27 In addition, various examples can be found on the 
combination of RENPs with plasmonic materials as gold or silver, which act as luminescence enhancers or provide plasmonic properties to 
the NPs.28 Finally, it is also possible to prepare nanostructures with a combination of different shell materials (sometimes described as 
core/shell/shell or core/spacer/shell NPs). These structures usually facilitate the growth of materials with very different lattice parameters, 
  
as it is the case of plasmonic materials on fluoride NPs (e.g., NaYF4@SiO2@Au, NaGdF4:Yb,Er@NaGdF4@Ag, and NaYF4:Yb,Er@ 
NaYF4@SiO2@Au).29-32 Additionally, they are used to control the distance between the RE ions and the plasmonic material, which is a 
fundamental parameter for the enhancement of the luminescence.28 
 
 
 
Technique Principle 
Thermal 
decomposition 
The precursor materials containing the dopant 
ions and the matrix components in the desired 
ratio are mixed in high boiling solvents (usually 
oleic acid and octadecene) and then heated to 
elevated temperatures (usually above 280 °C) 
that induce decomposition of the precursor 
and crystal formation (nucleation) of the 
nanoparticles. Precise control of the reaction 
temperature and time is necessary to achieve 
homogenous sizes and morphologies. 
Solvothermal 
synthesis 
The precursor materials are mixed in a 
pressure-resistant reaction vessel (autoclave) 
in the presence of a low boiling solvent that 
generates pressure in the vessel during the 
synthesis at temperatures above the boiling 
point but below the ones used in thermal 
decompositions. In the case of H2O the 
reaction is called hydrothermal and often 
allows the direct synthesis of water-dispersible 
NPs although control of size and morphology is 
less easily achieved. 
Microwave-assisted 
synthesis 
This type of synthesis usually combines the 
above approaches to some extent. The rapid 
heating of the whole mixture from the inside 
and the generation of hotspots favour a 
homogenous thermal decomposition, while 
the reactions are usually performed in sealed 
microwave tubes which add pressure as an 
element that otherwise is the key for 
solvothermal syntheses. 
 
Table 1. Short summary of the techniques usually employed for the synthesis of RENPs 
However, in this review article we focus on the cases where both core and shell contain RE ions. RENPs are usually based on fluorides, oxides, 
phosphates, vanadates, molybdates, and wolframates as basic inorganic crystals that form the matrix of the NPs. Although the matrix does 
not have to contain RE ions, these compounds normally facilitate the doping process with other RE ions of interest,33 hence matrices already 
including RE ions stoichiometrically are usually employed. Among the mentioned host materials, fluorides are the most commonly used in 
biological applications. 
Fluorides can be prepared following a variety of methods that include thermal decomposition, solvothermal, or microwave synthesis, among 
others. The preparation of the CS structures is usually a two-step procedure; the synthesis of the core NPs, followed by the addition of the 
starting material for the shell. This is, for example the case in thermal decompositions, where the strategy followed in Vetrone et al. work 
which represented the first approach for the use of a doped shell to enhance the emission of NaGdF4:Er,Yb UCNPs.34 The core was prepared 
by thermal decomposition of RE trifluoroacetates in high boiling organic solvents. After the synthesis of the core NPs was completed, the 
precursors (also trifluoracetates) of the shell material were injected into the reaction flask, allowing the growth of the new material on the 
surface of the already formed NPs. In these cases, where the material of the core and the shell are very similar, the formation of the shell is 
demonstrated by taking an aliquot from the synthesis flask after the first step (core synthesis) and before adding the precursors of the shell 
in the 2nd step. Then, the comparison of the size of the only core NPs with the ones after the 2nd step should demonstrate an increase in size 
of the CS NP due to the addition of the shell. The advantage of thermal decomposition methods for the growth of CS NPs is that they make 
it possible to continue the process in one pot and grow a desired number of shells through the stepwise injection of precursors which form 
  
additional layers or shells on the surface of the NPs without interrupting the synthesis.35 This layer-by-layer method for the addition of shells 
has the advantage of providing a very accurate control on the distribution of dopants in the different shells, which reflects in an increase of 
the luminescence efficiency as demonstrated in the work by Li et al (Figure 2a).36 These authors prepared CS NaGdF4:Yb,Tm@NaGdF4:Ln 
(Ln = Tb, Eu) NPs that showed an improvement of 20%–30% In their luminescence intensity when compared to the same materials prepared 
in a one step process. 
The disadvantage of the stepwise addition in one pot (layer-by-layer method) is that it usually requires a very precise control of the precursor 
injections in order to achieve homogeneous growth of the different shells. Therefore, mechanical pumps are often employed for the injection 
in order to control the temperature of the reaction flask, so it doesn’t suffer large variations during the introduction of the colder precursors. 
This drawback was solved by Quintanilla et al.37 by using a thermal decomposition method based on microwave heating, which allows to 
reach the synthesis temperature fast enough to achieve homogeneous decomposition of the precursors without dropwise injection and thus, 
homogeneous formation of the shell. In this case, they prepared small core/shell/shell structures of NaGdF4:Tm,Yb and NaGdF4:Er,Yb NPs. 
Through the distribution of the dopants in the core and different shells, they modified the intensity ratios of the different emission bands 
and, therefore, the overall emission colour. Finally, another possibility in thermal decomposition CS synthesis is the use of epitaxial growth 
for the shell formation, by the injection of small sacrificial NPs as shell precursors in a reaction flask containing the core NPs at 300˚C (Figure 
2b-e).38 The system experiences Ostwald ripening, so the sacrificial particles dissolve and deposit on the surface of the core NPs, forming 
highly homogenous CS NPs without the requirement of a highly controlled addition of precursors. 
CS nanostructures can also be prepared by solvothermal methods.39, 40 These procedures usually take longer reaction times and they require 
the recuperation and washing of the NPs after each synthesis step, so that the precursors for the shell can be added afterwards for the 
procedure to be repeated. In addition, the shape and size of the NPs is more difficult to control, so that few examples of NPs for biological 
applications obtained by this route can be found in the literature. However, this approach has the advantage of requiring relatively low 
temperatures during synthesis, so it is a good method for the preparation of sulfides, oxides, and similar materials, but usually for solid-state 
applications.39, 40 
C. RARE-EARTH-DOPED CORE-SHELL NANOPARTILES FOR BIOIMAGING 
In this section we highlight the main results achieved in the field of bioimaging by the use of CS RENPs, including results obtained 
in both in vitro and in vivo experiments, with special attention to the advantages achieved in respect to previously used optical 
probes. The section is divided into three sub-sections that aim to reflect the historic evolution of the application of CS RENPs in 
  
the field of bioimaging. In Subsection C.1 it is described how at first CS structures constituted by an inert shell were used to enhance 
brightness and stability of RENPs and, thus, to improve the quality of bioimages. In Subsection C.2 we review how active core-
active shell RENPs have been used to drastically minimize the laser induced thermal loading during in vivo imaging experiments 
just by making it possible to tune the excitation wavelength out of the 980 nm band. Finally, in Subsection C.3 we provide a general 
overview of the latest advances regarding the use of CS RENPs for multimodal in vivo imaging by using the different functionalities 
of core and shell units. 
C.1. Bioimaging with core-shell nanoparticles with an inert shell 
The outer shell in CS RENPS, as in other CS structures, usually behaves as isolator, protecting the luminescence of the ions in the 
inner core from non-radiative de-excitations. They can be produced by surface defects or by the interaction with external emitting 
units and medium molecules. Indeed, luminescent ions near the NP surface can be directly quenched by passivating ligands, the 
solvent, surface impurities, and surface lattice defects. Moreover, ions located far from the surface may also suffer from surface 
quenching effects due to the possible presence of energy migration processes.41 For instance, widely used Yb3+ ions are prone to 
suffer energy migration processes due to its two-level configuration and long-lived emission. The use of passivating non-doped 
shells prevents surface quenching as the ions at NP´s surface are not in physical contact with molecules of the medium. This 
strategy may achieve, in CS RENPs, an increase of the emitted intensity of up to 350 times, enlarging the lifetime more than twice.42 
This enhancement is reflected to a different degree in the intensity of the diverse emission bands of the system.43-45 The potential 
brightness enhancement that could be achieved by the use of an inert shell has been demonstrated in different systems. Of special 
significance are the results provided by Shen et al.46 who studied the enhancement of the emission in UCNPs, comparing the 
emission of the different crystalline phases of this matrix. α-NaYF4:Yb,Tm@CaF2 offered triple the intensity in the ultraviolet 
emission band of Tm3+ ions and it was much less quenched than β-NaYF4:Yb,Tm@β-NaYF4 when transferred to aqueous solvents, 
as shown in Figure 3a. Moreover, these authors observed the rise in the ultraviolet emission in α-NaYF4:Yb,Tm@CaF2 NPs with the 
amount of sensitizer ion (Yb3+) in the NP only if the passivating shell was employed (see Figure 3b). This data revealed that the 
presence of the inert shell does not only provide a way to increase emitted intensities, but also to tailor the spectral properties of 
the nanostructure. Furthermore, the activation of caged fluorescein in HeLa cells by the enhanced ultraviolet emission of Tm3+ ions 
was studied as an application of the developed CS RENPs (see Figure 3 and Section E of this review for information about 
photoactivation processes). 
At this point we should note that the removal/reduction of non-radiative processes due to the presence of an inert shell was 
demonstrated to also have a clear signature in the fluorescence decay rates. This was demonstrated by Liang et al.47 who added a 
non-doped shell to eliminate vibration-induced non-radiative processes in aqueous dispersions of 
NaYF4:Nd,Yb@NaYF4:Yb,Tm@NaYF4 NPs (see Figure 4a). The presence of the inert shell lead to a longer lifetime for the 3H4→3H6 
  
transition of Tm3+ ions, as shown in the intensity decay plots of Figure 4c. However, this passivating shell reduced considerably the 
rate of two-photon population on the 3H4 state of Tm3+ ions. Other works have also observed the effect of non-doped shells on 
the emission intensity of Tm3+ ions at about 800 nm, with up to 30 times intensity enhancement and tripled lifetime values.48 
An interesting question always arises when talking about CS RENPs with inert shells: which is the optimum shell thickness? In this 
sense, some works have observed that the usual thickness of 1-3 nm is not always fully effective in aqueous dispersions.49 Zhong 
et al.50 studied the quenching of the Er3+ emission in the third biological window of transparency of the tissues (1500-1800 nm) in 
NaYF4:Er,Yb,Ce@NaYF4 NPs in aqueous dispersions, which is produced by a two-phonon quenching of the OH- groups vibrations 
(see illustrative diagram in Figure 3d). The quenching was assessed depending on the inert shell thickness, as shown in Figure 3e. 
By increasing the distance between lanthanide ions and surface quenchers, the effect was reduced. For emissions easily quenched 
by OH- groups as Er3+ in the NIR, an isolating shell of a thickness up to 7 nm is needed to maximize the emission intensity (see 
Figure 3f). The performance of these NPs was tested in dynamic non-invasive brain vascular imaging with excellent temporal 
resolution by monitoring the emission of Er3+ ions in the third biological window, what allowed the measurement to be performed 
at high penetration depths in the brain. Figure 3g displays a spatially resolved blood-flow map of the brain, i.e. the plot of the 
distance travelled by the blood flow as a function of time.  
Finally, we should mention that the increase in the brightness of RENPs by surface passivation by CS engineering allowed to reduce 
the excitation power applied to the specimen and thus the side effects of the procedure.48 Moreover, in addition to the 
minimization of interaction between emitting ions and medium molecules, inert shells are being also used to prevent the non-
radiative de-excitations produced by outer shells,51 to avoid energy transfer between active shells with different functions,43, 52 to 
impede interparticle ion exchange,53 and even to include extra functionalities for multimodal bioimaging (see Section C.3.).52, 54-56 
C.2. Heating-free bioimaging with active core-active shell nanoparticles 
The typical sensitization of most VIS emitting RENPs by means of Yb3+ leads to an undesired deleterious heating. This is produced 
due to the overlap of the Yb3+ excitation at 975 nm and water absorption at this wavelength, which also shortens the penetration 
depth of the excitation.57 Some attempts to excite Yb3+ ions avoiding the absorption band of water were made by using different 
excitation wavelengths, but the low absorption cross section of this ion far from 980 nm makes it impossible to achieve high 
emission intensities from the activator ions.45 As a substitute for Yb3+ ions, Nd3+ has become the preferred sensitizer ion for 
bioimaging. Its excitation at either 745 or 800 nm, when compared with the typical sensitization by means of Yb3+ ions (980 nm), 
results in better penetration depths and reduced absorption by water molecules. Moreover, the emission lines of Nd3+ in the NIR 
are of great interest as they are within the NIR first and second biological windows (spectral regions within the 700-950 and 1000-
1350 nm spectral ranges in which tissues are partially transparent).58 Nd3+→Yb3+→activator energy transfer has been extensively 
used over the last years for the development of UC VIS-emitting RENPs without thermal loading and proving an even more intense 
emission intensity due to the larger absorption cross-section of Nd3+ at around 740 and 800 nm.47, 59 This was possible thanks to 
CS engineering, as the codoping with Nd3+ and activator ions could lead to severe quenching of their emissions so that it becomes 
essential to separate Nd3+ (donors) from VIS-emitting ions (acceptors such as Er3+).60  
Concerning this challenge, Liang et al.47 studied the heating caused by the excitation at 980 nm and they designed a CS RENP with 
good prospects for bioapplications under excitation at 745 nm. CS UCNPs were excited at 745 nm, with Nd3+ ions as the sensitizer 
of the Tm3+ emission at around 800 nm (see illustrative diagram in Figure 4a). The excitation spectra of this system (see Figure 4b) 
proved the possibility of exciting Nd3+ ions both at around 800 and 745 nm. These excitation wavelengths avoid undesired 
overheating issues. As shown in Figure 4d, tissue exposed to 980 nm laser irradiation suffered more than 5-fold heating in 
comparison to when irradiated at 745 nm (under the same experimental conditions). The effect of the overheating produced by a 
980 nm laser was also tested in vitro with HeLa cells. Cell viability was studied for various irradiation times and, as expected, 745 
nm light did not affect cell viability but 980 nm light produced hyperthermia in cells even at low exposure times, as shown in Figure 
4e and 4f (see section E for more information about hyperthermia). 
Sensitization by means of Nd3+ ions presents other advantages. For example, although indirect excitation of Yb3+ ions by means of 
energy transfer from Nd3+ may reduce the subsequent UC luminescence intensity, the higher penetration depth of 808 nm 
excitation results in a more intense signal from the NPs in in vivo experiments, as shown in Figure 4g.61 In addition, Figure 4h shows 
the extreme and fast heating of a mouse under irradiation with 980 nm light, while the laser exposure at 808 nm does not produce 
significant heating even at longer exposure times.61 This fact is crucial for LNPs-assisted treatments, which usually require long 
exposure times (see section E).62  
With a different approach, a tuneable (700-860 nm) and more efficient excitation of LNPs was achieved by Shao et al.63 using 
indocyanine green organic dye molecules as sensitizers attached to the NaYF4:Yb,X@NaYbF4@NaYF4:Nd (X = null, Er, Ho, Tm, or 
Pr) NPs surface. The energy absorbed by the dye is transferred to Nd3+ ions in the outer shell, which allows to excite Yb3+ ions in 
the inner shell and, by energy migration, to diverse activator ions in the core. This strategy allowed a 4-fold emitted intensity 
increase in diverse luminescent ions, due to the higher absorption of the dye molecules and the overlap of its emission with the 
  
absorption of Nd3+ ions. This strategy is crucial for facing the 
low absorption of lanthanide ions. It has recently been used not 
only in diverse applications in nanomedicine,64 but also in 
renewable energies,65 for instance. 
These advances in CS engineering led not only to thermal 
loading minimization, but also to a relevant increment of their 
penetration depth. This was achieved by means of excitation 
wavelengths that are barely absorbed by tissues, such as 745 
and 808 nm.43, 47 Furthermore, an emission intensity increase 
due to a more efficient sensitization and the reduction of non-
radiative de-excitations can also result in an improved 
penetration depth.47, 63 
C.3. Core-shell nanoparticles for multimodal imaging 
The chemical similarity but large spectroscopic and physical 
differences between RE ions make them ideally suited as 
generators of multifunctionality (or multimodality in the case of 
bioimaging). This makes it easy to select a range of dopants and 
embed them in the same NP matrix while generating a wide 
range of functionalities. This approach is further fine-tuned 
with the application of CS architectures as discussed in the 
following paragraphs. Table 2 gives an overview of the 
application of CS RENPs as contrast agents in combined imaging 
techniques. 
C.3.1. Core-shell nanoparticles for X-ray, computer-based 
tomography, and magnetic resonance imaging 
The most commonly applied imaging techniques in the clinic 
are radiography and computer-based tomography (CT), both 
based on X-rays. They are routine techniques in whole body as 
well as organ imaging. Therefore, multimodal NPs that not only 
present the potential for optical bioimaging, but also can act as 
CT contrast agents have a high potential to advance RENPs into 
commercial applications. Here NPs with a high amount of heavy 
lanthanides can work as X-ray attenuators and thereby enhance 
the contrast. 
The first CS RENPs capable of CT contrast were presented in 
2013 based on a NaLuF4 core,66 being Lu the heaviest of the RE 
ions, and a protecting NaGdF4 shell (also useful for magnetic 
resonance imaging (MRI) thanks to Gd ions). Furthermore, the 
4 nm thick NaGdF4 shell was doped with traces of radioactive 
153Sm as a single photon emission computed tomography (SPECT) contrast agent. This structure, schematically depicted in Figure 
5e, allowed for combined optical, CT, MRI, and SPECT imaging, as shown in Figure 5a-d and 4f. 
During the same year, Shen et al.67 presented a four-layer multimodal NaYF4-based design with two inner shells, one of them 
containing NaLuF4 for CT imaging and a second inert NaYF4 shell, combined with the first one, used for separating the UC 
NaYF4:Yb,Tm core from the thin outer NaGdF4 layer aimed for MRI. This separation was necessary in order to prevent quenching 
of the activator Tm3+ ion in the core, responsible for optical imaging, via Tm→Gd energy transfer. This demonstrates how a rational 
design of the employed shells can help with multifunctionality. 
Later in 2014, Wang et al.55 presented a multi-shell (2 active, 1 inert) approach for multimodal UC bioimaging. Sensitizer Nd3+ ions 
were placed in the next-to-outer-shell, from which energy transfer to the Er3+ doped core took place via Yb3+ ions in the inner shells 
and the core. The core and the shells were based on NaLuF4 as matrix, presenting excellent contrast properties in CT scans in both 
in vitro and in vivo, while the core also contained Gd3+ ions improving the T1-relaxivity and adding MRI-imaging to the multimodal 
capabilities.
Figure 4. Avoiding deleterious heating due to 980 nm excitation. (a) Schematic 
illustration of NaYF4:Nd,Yb@NaYF4:Yb,Tm@NaYF4 CS RENPs. (b) Excitation map of 
these CS RENPs. Excitation spectra at the maximum of Yb3+ emission (977 nm) is 
included on top. (c) Time-resolved emission map of NaYF4:Nd,Yb@NaYF4:Yb,Tm and 
NaYF4:Nd,Yb@NaYF4:Yb,Tm@NaYF4 CS RENPs under 745 nm excitation. (d) 
Spatiotemporal temperature distributions on rat back skin before (left) and after 
irradiation (250 mW cm-2 laser power density) for 5 min with 745 nm (centre) and 980 
nm laser (right). (e) Cell viability (MTS assays) of HeLa cells irradiated with 745 nm and 
980 nm lasers for different time intervals. (f) Fluorescent cellular images after 
irradiating for 10 min (green and red staining used for labelling live and dead cells, 
respectively). Reprinted from 47. Copyright 2016 Wiley-VCH Verlag GmbH & Co. KGaA. 
(g) In vivo UC imaging of a nude mouse subcutaneously injected with 
NaGdF4:Yb,Er@NaGdF4:Nd,Yb CS RENPs. The images were obtained under 980 nm 
laser (left) and 808 nm laser (right) irradiation (power density of 200 mW/cm2; regions 
of interest are denoted by black dot circles). Insets: schematic diagram of the energy 
transfer processes under the diverse excitation wavelengths. (h) NIR thermal image 
of a nude mouse under continuous 980 nm laser irradiation for 50 s (top) and 808 nm 
laser irradiation for 300 s (bottom). The white arrows denote the irradiation spots. 
Reprinted with permission from 61. Copyright 2013 American Chemical Society.  
  
CS RENP 
Additional imaging techniques 
Reference 
CT / X-ray MRI Others 
NaGdF4:Yb,Er@NaGdF4 X X  44 
Na0.52YbF3.52@SrF2 X X  45 
NaYF4:Yb,Er@NaGdF4@SiO2  X  54 
NaLuF4:Gd,Yb,Er@NaLuF4:Yb@NaLuF4:Nd,Yb@NaLuF4 X X  55 
NaYF4:Yb,Er,Tm@NaGdF4@TaO X X  56 
NaGdF4:Yb,Er@NaGdF4:Yb@NaGdF4:Yb,Nd@mSiO2  X  59 
NaGdF4:Yb,Er@NaGdF4:Nd,Yb  X  62 
NaLuF4:Yb,Tm@NaGdF4(153Sm) X X SPECT 66 
NaYF4:Yb,Tm@NaLuF4@NaYF4@NaGdF4 X X  67 
NaYF4:Yb,Er@NaGdF4:Yb@mSiO2+ZnO X X  68 
Y(OH)CO3:Yb,Er@Y(OH)CO3:Yb X   69 
NaGdF4:Yb,Er@NaGdF4:Yb@mSiO2-Dopa X X  70 
NaGdF4:Yb,Er@NaGdF4  X  71 
NaYF4:Yb,Tm,Gd@NaGdF4  X  72 
NaDyF4:Yb@NaLuF4:Yb,Er@polydopamine  X  73 
NaGdF4:Yb,Er@NaGdF4:Yb@NaNdF4:Yb+Au25   PA 74 
NaGdF4:Nd@NaGdF4:Yb,Er@NaGdF4:Yb@NaNdF4:Yb+Au25   PA 75 
NaYbF4:Tm@NaYF4@porphyrin-phospholipid X X PA, PET, Cherenkov 76 
NaYF4:Yb,Er@Yb,Nd@SiO2+ICG   PA 77 
Table 2. Core-shell nanoparticles used for multimodal imaging in the different discussed examples. The imaging techniques which are 
combined with inherent luminescence are detailed. 
  
In 2014 Tian et al.44 demonstrated that NaGdF4:Yb,Er UC RENPs coated with an inert shell of the same matrix were not just capable 
of UC optical imaging and acting as MRI contrast agents, but also respectable radio attenuators. The presence of heavy Gd and Yb 
was sufficient to achieve better CT contrast than with commercial contrast agents, thus no integration of Lu in the structure was 
necessary. 
One of the earliest examples of CS NPs with radio attenuation in the literature dates from 2012.56 Typical RENPs for UC 
luminescence imaging (NaYF4:Yb,Er,Tm) were converted into multimodal imaging agents by adding a NaGdF4 shell and decorating 
it with a heterogeneous TaOx layer. The TaOx layer had the form of small NPs in silica with added PEG for better water dispersibility 
and resulted in 30 nm sized NPs with a rough/dented surface due to the TaOx NPs decorating the surface. Ta presented, together 
with the Gd, an excellent CT and MRI contrast without impeding the UC luminescence. This multimodal ability was demonstrated 
in trimodal imaging experiments in mice. 
In 2016 the Lin’s group presented an interesting approach to improve the optical imaging of trimodal (UC luminescence, CT, MRI) 
Na0.52YbF3.52@SrF2 CS RENPs.45 The scarcity of Na during the synthesis created sub-stoichiometric particles with an improved red 
emission facilitating the UC luminescence imaging, while CT and MRI contrast were achieved solely based on Yb3+ ions. 
Wang et al.68 presented in 2015 UC RENPs for trimodal imaging with an added mesoporous silica-shell for drug delivery, which also 
allowed them to vary the CS architecture by placing Yb3+ not just in the NaYF4:Yb,Er core, but also in the intermediary NaGdF4:Yb 
shell, while the outermost shell was mesoporous silica decorated with ZnO quantum dots as gatekeepers for drug release in an 
acidic medium. A similar approach was previously reported employing Tm3+ instead of Er3+ and a different surface functionalization. 
This example is discussed in Section E.1. 
The only non-fluoride CS host also employed for multimodal bioimaging was reported by Lv et al. in 2015.69 Their CS RENPs were 
designed mainly for drug delivery and therapy (for more details see Section E), but they are an interesting example of oxide-based 
Figure 5. CS RENPs for multimodal imaging. In vivo (a) UC luminescence (ex. 980 nm), (b) CT, )c) SPECT, and (d) MRI Images (false colours) of UC CS RENP-marked tumour on mouse 
1 h after intra venous injection. (e) Schematic representation of the NaLuF4:Yb,Tm@NaGdF4 (153Sm) UC CS RENPs employed in a-d and f. (f) Confocal UC luminescence microscopy 
of an ex vivo paraffin section of the tumor demonstrating the presence of UCNPs inside the tissue. Reprinted with permission from 66. Copyright 2013 American Chemical Society. 
(g) Another example of the use of UC CS RENPs for bioimaging. Schematic representation of the experiment where CS RENPs were functionalized with a protein (ANG) to recognize 
angiogenesis of glioblastomas and thereby pass the blood-brain barrier. (h) Ex vivo brightfield and luminescence images of mice brain 1 h after injection. The top row shows ANG-
functionalized UCNPs that have passed to the brain and mark the tumour region with a strong signal. Unfunctionalized UC CS RENPs in middle row do not target the area of interest. 
Bottom row shows a control experiment where a dye passes through blood-brain barrier but it does not selectively mark the tumour. The right column shows stained histograms 
demonstrating the presence of glioblastoma. Reprinted with permission from 72. Copyright 2014 American Chemical Society. 
  
CS structure, which was obtained in a controlled calcination of the hydroxyl carbonates of the lanthanides 
Y(OH)CO3:Yb,Er@Y(OH)CO3:Yb. As can be seen from the dopants, these CS RENPs allowed UC luminescence bioimaging and 
provided CT contrast, which was demonstrated in mice. Recently Lv et al.70 also reported multifunctional and multimodal UC CS 
RENPs based on a more typical architecture (NaGdF4:Yb,Er@NaGdF4:Yb@mSiO2-Dopa), thereby achieving smaller particle size and 
adding MRI to the imaging capabilities. 
One of the first CS based multimodal imaging (MRI and luminescence) examples had already been published in 2009 by Park et 
al.71 They studied functionalized NaGdF4:Yb,Er@NaGdF4 NPs in cellular models and were able to perform single particle 
luminescence imaging with a modified atomic force microscopy setup, demonstrating the brightness increase achieved by 
incorporating the shell. 
Ni et al.72 presented UC CS RENPS with an inert NaGdF4 shell (NaYF4:Yb,Tm,Gd@NaGdF4) and functionalized with PEG and a short 
peptide for Glioblastoma targeting (Angiopep-2) that were employed to image brain tumours with MRI in vivo and with UC 
luminescence ex vivo. Figure 5g schematically shows the particle design and the targeting process of the glioblastoma by means of 
the peptide. Figure 5h demonstrates the precision of the targeting by fluorescence imaging of the excised brain and a comparison 
with classical staining of the tissue sample. 
A multifunctional dual imaging probe (MRI and UC luminescence) with a rational design for excitation at 808 nm, was presented 
by Li et al.62 in 2016 with a CS architecture (NaGdF4:Yb,Er@NaGdF4:Nd,Yb) placing Nd3+ ions as sensitizer in the shell and employing 
Yb3+ for energy transfer to the core, in order to achieve Er3+-based UC luminescence, but also employing the Yb3+ emission at 980 
for NIR imaging. This allowed the combination of optical imaging with T2-weighted MRI based on Gd, while also adding a sensitized-
dye for photodynamic therapy (PDT, see section E.2) excited by UC luminescence. 
Zeng et al.59 also presented 808 nm excited CS RENPs for a theranostic approach against breast-cancer. They presented 
functionalized and silica-coated core-shell-shell NPs (NaGdF4:Yb,Er@NaGdF4:Yb@NaGdF4:Yb,Nd@mSiO2), whose UC luminescence 
was employed in in mice models and the Gd of the host matrix for MRI. The intermediary NaGdF4:Yb shell was included to achieve 
a larger separation between the sensitizing Nd3+ions and the emitting Er3+ ions in the core. In this manner, energy back transfer 
from the activator to the sensitizer was suppressed. The mesoporous silica shell included covalently attached Ce6, an organic dye 
for PDT, which was activated through the UC luminescence. Furthermore, functionalization of the surface with a peptide helped 
with active targeting of the Her2 breast cancer. 
Fan et al.54 presented already in 2013 a hollow shell approach for theranostic application in cancer treatment. They synthesized a 
typical CS structure for multimodal imaging (UC luminescence and MRI) NaYF4:Yb,Er@NaGdF4, on which they added two layers of 
dense silica and finally PVP as a surface coating. This allowed them to treat the silica layers away from the inner layer with hot 
water etching while the outer layer was mostly protected by the polymer and therefore only slightly attacked, converting itself 
into a mesoporous silica shell around a cavity that included the UC CS RENPs. In this manner a so called rattle or yolk shell (YS) 
structure was obtained that was additionally loaded with cis platin for chemo- and radiotherapy. The YS RENPs were successfully 
employed in murine studies for the treatment of HeLa tumours. 
Dual-mode MRI-imaging (T1 and T2) and UC luminescence via a CS architecture was presented in 2016 by Zhou’s group.73 Preferring 
the also paramagnetic Dy over typically employed Gd, they synthesized CS NaDyF4:Yb@NaLuF4:Yb,Er@polydopamine, achieving 
water-dispersibility and biocompatibility through surface-coating with polydopamine. Furthermore, they modified the 
polydopamine with EDTA and complexed Mn2+ on the CS RENPs. They demonstrated in vivo T2-weighted-imaging based on Dy and 
T1-weighted-imaging based on the Mn-complex on the surface. Additionally they were able to show the potential for photothermal 
therapy (see section E.3) due to heating by the polydopamine when excited at 980 nm. 
C.3.2. Core-shell nanoparticles for photoacoustic imaging 
In recent years, photoacoustic (PA) imaging has become a popular technique combining the PA effect (absorbed energy generates 
heat and a thermoeleastic expansion which causes a wideband ultrasonic emission) with ultrasound techniques. Usually, intrinsic 
chromophores as haemoglobin or organic dyes that absorb pulsed laser radiation are employed and the ultrasonic signal is received 
by transducers and analysed. UC CS RENPs therefore can also be modified with strongly absorbing PA agents for a different form 
of multimodal imaging. 
In 2015 He et al.74 combined NaGdF4:Yb,Er@NaGdF4:Yb@NaNdF4:Yb CS RENPs excitable at 808 and 980 nm with Au25 nanoclusters. 
These CS RENPs were loaded into a mesoporous silica shell and further functionalized with a PEG-surface coating. Not only the 
gold nanoclusters were able to perform PDT, but their strong absorption and heating capabilities also resulted in the addition of a 
PA imaging modality to the UC luminescence of the UC CS RENPs. In 2016 they expanded on this work by changing the core and 
the inner layer presenting NaGdF4:Nd@NaGdF4:Yb,Er@NaGdF4:Yb@NaNdF4:Yb as CS RENPs with better heating and imaging 
capabilities and then adding the gold nanoclusters. As was the case in the first example, they demonstrated photoacoustic imaging 
in vivo.75 
  
Demonstrating the possible versatility in bioimaging by means 
of UC CS RENPs, Rieffel et al.76 added PA imaging via surface 
functionalization with a porphyrin-phospholipid to 
NaYbF4:Tm@NaYF4 UC CS RENPs. This also allowed the easy 
labeling of porphyrine with radioactive 64Cu, also allowing for 
positron emission tomography (PET) and Cherenkov multimodal 
imaging. This was achieved in addition to the luminescence (UC 
and porphyrine-based) and CT-contrast already provided by the 
core and inert shell of the NP. Rieffel et al. successfully used this 
multimodal nanoplatform to visualize the lymphatic node in a 
hind leg of mice. 
In 2017 Prasad’s group77 presented 808 nm-excitable UC CS 
RENPs that had an additional mesoporous silica shell loaded 
with an NIR organic dye and it was sealed through treatment 
with TEOS, preventing the release of the dye (Indocyanine 
green). This allowed them to present in vivo dual mode imaging 
in the form of UC luminescence and PA imaging with the FDA-
approved dye. Storing the dye inside the silica layer helped to 
protect it from the biological environment and to transport it to 
the desired location. Additionally, the group demonstrated that 
the CS RENPs were also good nanoheaters and that their 
nanomaterial could be also employed in photothermal therapy. 
D. CORE-SHELL RARE-EARTH-DOPED 
NANOPARTICLES FOR BIOSENSING 
In this section a general view of the latest advances achieved in 
the field of biosensing by using CS RENPs is provided. Biosensing 
is here defined in a wide sense. We consider that biosensing is 
being achieved when additional information, different from 
biodistribution, is obtained from the analysis of the bioimages 
produced by using the CS RENPs. When revisiting the literature, 
the CS RENPs employed for biosensing can be classified into two 
main blocks: thermal and molecular/chemical biosensing. 
Accordingly, this section is structured into two subsections. 
Section D.1 aims to provide the reader with a general 
description of the state of the art regarding the use of CS 
structures for thermal sensing in biological systems. Then, 
Section D.2 provides some examples in which CS RENPs have 
been used for chemical biosensing.  
D.1. Core-shell rare-earth-doped nanoparticles for thermal sensing 
The most frequent application of RENPs for sensing is in thermometry, due to the sometimes outstanding thermal sensitivity of RE 
ions. The synergy between nanothermometry, CS engineering, and nanomedicine led to the appearance of self-referenced heating 
agents for thermal therapies. The first example was the work published by Piñol et al.78 in 2015, demonstrating how a CS structure 
was able to provide real time thermal control to magnetic nanoparticles (see Figure 6a). The thermometer/heater NP was an iron 
oxide surrounded by Eu3+ and Tb3+ complexes and overall coated with a copolymer (P4VP-b-P(PMEGA-co-PEGA)), as shown in 
Figure 6a. In this structure the core was the magnetic heater, while the shell was a thermosensitive luminescent unit. The authors 
developed this CS structure to improve the efficacy of the localized magnetic heating and to obtain optical temperature readout. 
Temperature sensing was obtained by means of the UV excited Tb3+ and Eu3+ emission bands centred at 545 and 615 nm, 
respectively. The ability of this RE doped coating for accurate thermal sensing was demonstrated by performing simple in vitro 
experiments by analysing fluorescence cellular images after incubation with CS NPs as those represented in Figure 6(a). Figure 6c 
and 6d shows, respectively, the fluorescence images corresponding to a single kidney cell as obtained by detecting the emission 
intensities at around 540 nm (Tb3+) and 610 nm (Eu3+). The thermometric mapping at subcellular scale (Figure 6e) was obtained by 
simply taking the ratio of the images in Figure 6c and 6d. Piñol et al. claimed a temperature resolution as good as 0.5 K from the 
Figure 6. (a) Schematic scaled representation of an optical-magnetical NP. In the 
central region, Eu3+ and Tb3+ complexes (reddish layer) for temperature 
measurement cover the maghemite NPs (orange). The P4VP (green) forms a first 
shell encapsulating the magnetic NPs and the P(PMEGA-co-PEGA) chains (blue) 
occupy the outer part. (b) The histogram of the temperature distribution near the 
opossum kidney cells´ nucleus and its fit to a Gaussian distribution of mean value 
299.3 ± 0.2 K, in agreement with the cell culture temperature. Temperature 
mapping of OK cells, showing the (c) Eu3+ (around 610 nm) and (d) Tb3+ (around 545 
nm) emissions. The interrupted lines delimitate the nucleus of the opossum kidney 
cell, marking the region of interest within which the temperature map showed in 
(e) was computed. All scale bars correspond to 10 μm. (f) Temperature 
measurement of the same suspension during a 300 s multipulse experiment using 
the molecular (blue circles) and semiconductor (red circles) thermometers. The 
shadowed areas mark the time intervals when the magnetic field is turned on (15 
s). The solid lines correspond to the fit of experimental data with the lumped 
elements model. Adapted with permission from 78. Copyright 2015 American 
Chemical Society. 
  
temperature histogram included in Figure 6b. The good thermal sensitivity of the luminescent shell was then applied to real time 
monitoring of the local heating produced when an alternating magnetic field was applied to a colloidal suspension of these 
optomagnetic CS structures (see Figure 6f). The demonstration of simultaneous magnetic heating and thermal sensing provided 
by Piñol et al. had a great practical impact, since it does not only show the possibility of thermal control in magnetic thermal 
therapies, but also opened the door to the study of thermal dynamics at the nanoscale. 
A successful example of thermal sensing achieved in living animals by means of CS RENPs was provided by LaF3:Nd@LaF3:Yb CS 
NPs. 79 These NPs are constituted by a Nd3+ doped core and a Yb3+ doped shell. When optically excited at 790 nm, energy transfer 
from Nd3+ to Yb3+ ions can occur, assisted by energy migration between Nd3+ ions. As a consequence of energy transfer processes, 
radiative decays from the metastable states of both Nd3+ and Yb3+ ions take place simultaneously, resulting in a multi-band 
emission in the second biological window. Due to the spatial separation between Nd3+ and Yb3+ ions, the spectral distribution of 
the overall emission spectrum results strongly temperature dependent. The NIR thermal sensitivity provided by the ratiometric 
analysis of the luminescence generated by LaF3:Nd@LaF3:Yb NPs was close to 0.4% ᵒ C-1, which is good enough to achieve subdegree 
thermal readings. In fact, the CS RENPs ability for accurate measurement of in vivo subcutaneous thermal transients (see scheme 
of the experiment in Figure 7a) is a potential theranostic tool successfully explored by Ximendes et al.79 The physical principle 
behind the experiment relied on the fact that when a tissue undergoes a thermal relaxation (temperature decrease in the absence 
of any heating source, see Figure 7a and 7b), the cooling dynamics strongly depends on the intrinsic properties of the tissue. Thus, 
an accurate measurement of the cooling relaxation profile is capable of providing information on the tissue status and could be 
used to detect anomalies caused by incipient diseases such as dehydration, inflammation, tumour growth, or even ischemia, as 
recently demonstrated.80 Indeed, the analysis of the thermal relaxation curve of a tissue (included in Figure 7b) provides, 
simultaneously, accurate and consistent values for the tissue thermal conductivity and absorption. This work supported the validity 
of the use of CS RENPs as accurate and reliable subcutaneous thermal sensors for in vivo applications.81-84 
In the past few years, various CS RENPs emitting in the second biological window while being excited by a wavelength within first 
biological window have been reported as promising nanothermometers. Recently, Skripka et al.85 presented an optical 
nanothermometer working within the third biological window. It consisted in a multishell system of β-NaGdF4 with the core doped 
with Er3+, Ho3+, and Yb3+, a first shell doped with Yb3+, a second shell doped with Nd3+ and Yb3+ and an undoped passivating outer 
shell. The temperature dependent energy transfer between the Ho3+ - Nd3+ and Er3+ - Nd3+ NIR emission bands pairs presented a 
maximal thermal sensitivity in the physiological temperature range of 1.17 ± 0.04 % oC-1. This system constituted the very first 
nanothermometer working in aqueous environments within the second (Ho3+/Nd3+) and third (Er3+/Nd3+) biological windows. 
Despite of these proofs of the ability of CS RENPs for local thermal reading, many challenges remained to be faced in the field of 
luminescence if it is aimed to apply it at the pre-clinical level. For instance, the acquisition of two-dimensional subcutaneous 
thermal images (2D-SDTI) is nowadays required for thermal-based diagnosis. This challenge has been recently overcome by using 
LaF3:Er,Yb@LaF3:Tm,Yb CS RENPs.86 The temperature dependent non-radiative energy transfer between Tm3+ and Yb3+ ions results 
  
in a multiband emission spectrum within the second biological window. Ratiometric thermal sensitivities as large as 4% ᵒC-1 were 
achieved when monitoring the intensity ratio between the emitted intensity of Yb3+ ions at 1000 nm and that of Tm3+ ions at 
around 1230 nm. This superior thermal sensitivity together with their emissions in the second and third biological windows made 
the achievement of in vivo time resolved 2D-SDTI possible. The simple experimental set-up required for 2D-SDTI is schematically 
shown in Figure 7c. Figure 7d and 7e includes the ratiometric thermal in vivo images obtained at different times during heating 
and cooling processes. The time evolution of the subtissue temperature (see Figure 7f) allowed the estimation of the thermal 
diffusivity of living tissue.87 The thermal diffusivity of living tissue 
provided by CS NPs was found to be in excellent agreement with 
those reported in the literature. Such agreement supports the 
validity of using CS RENPs as accurate and reliable probes for 
diagnostic procedures based on the acquisition of 2D-SDTI.79 
Indeed, the results obtained by Ximendes et al. opened the 
venue to new diagnosis and control techniques that could 
revolutionize existing methods in biomedicine. 
D.2. Core-shell rare-earth-doped nanoparticles for biological 
labeling 
RENPs can also be suitably conjugated with appropriate 
molecules as effective probes for biological labeling and 
biosensing.88 For a description of the recent development of the 
RE-based luminescence biolabelling, we recommend the review 
by Sy et al.89 The use of the CS engineering as method of 
improving the biological labelling, however, is something still in 
development, although the advantages of using these 
structures, reported in previous sections, will foster the advance 
of this field. 
The detection of single nucleotide polymorphisms (SNPs) is very 
important for the diagnosis of various diseases. The existing 
methods for the detection of SNPs, however, are based on 
quantitative RT-PCR (reverse transcription polymerase chain 
reaction), which is a time-consuming and expensive method. 
Fortunately, CS engineering provides an alternative method. CS 
RENPs are used for labelling DNA fragments. Fe3O4/Gd2O3:Eu 
magnetic and luminescent CS NPs were functionalized with 
neutravidin and then coupled to probe DNA fragments 
(complementary of the target DNA carrying a polycystic kidney 
disease mutation).90 Genomic DNA was then extracted from the 
tissue and the region of study (the one containing the 
polymorphism) was amplified and hybridized with a 
complementary strand labelled by an organic dye. When the 
sample DNA and the probe DNA coupled to the CS NP are mixed, 
hybridization takes place preferentially for the correct SNP. The 
hybridized fragments containing CS NPs are separated from the 
solution by a magnet and the luminescence ratio between Eu3+ 
and organic dye reveals the fraction of bound DNA. The 
presence of a given polymorphism is thus detected by means of 
the luminescence. The combination of quantification by 
luminescence and magnetism for separation yields a powerful 
method for quantitative detection of SNPs. 
Another representative example of biosensing by CS RENPs can 
be found in the pioneering work published by Zou et al.,91 who 
designed and synthesized a ClO- detection system based on a 
Nd3+-sensitized UC CS RENP. As represented in Figure 8a, the 
authors developed a complex nanosystem whereby a core, 
constituted by a NaYF4:Yb,Nd,Er NP, was surrounded by an 
active shell of NaYF4:Nd that would act as an energy donor and 
  
a ClO- responsive cyanine dye hCy3 as an energy acceptor. When such nanostructures were excited using a 808 nm laser, the Nd3+ 
ions acted as sensitizers to produce UC emissions from Er3+ (see Figure 8b) by energy transfer through Yb3+ ions. It should be 
highlighted that the UC emission of NaYF4:Yb,Nd,Er@NaYF4:Nd CS RENPs was significantly enhanced when compared to the simple 
NaYF4:Yb,Nd,Er RENPs. Furthermore, as the broad absorption band of hCy3 (450–580 nm) matched with the green UC emissions 
of Er3+, these bands were modulated by the presence of ClO-, which arose from the reaction between hCy3 and NaClO. The ClO- 
could react with the conjugated cyanine dyes (to form the corresponding oxindole), reducing its ability to absorb the green 
emission bands from UC CS RENP, thus green emission increases as the ClO- concentration does. In addition, due to the small 
overlap between the 630-670 nm red emission band of the CS UC RENPs and the absorption band of hCy3, the red UC emission 
was not influenced by the presence of ClO-, thus it was used as a reference parameter (see Figure 8b). Inset in Figure 8b shows the 
change in the intensity ration between green and red emission bands as a function of NaClO concentration, which evidences an 
increase in ClO- concentration. The real potential of these complex nanostructures for the detection of small variations on ClO- 
concentration was successfully demonstrated in in vitro and in vivo experiments. In the case of in vitro experiments the presence 
of ClO− was detected by ratiometric UC luminescence imaging under 808 nm excitation (see Figure 8c-l). In the absence of ClO-, an 
initial luminescence imaging investigation revealed low signal intensity for green emission band and a relatively intense red 
emission band (figure 8d and 7e). However, after the consecutive incubations with 5𝜇𝜇M NaClO for 30 min and the complex 
nanosystems, a great enhancement in the green emission band was observed in the intracellular region, showing an increase in 
ClO- intracellular concentration. This result show the potential of the use of ratiometric upconversion luminescence imaging 
between 500–560 nm and 600–700 nm emission bands as the detection signal, as shown in Figure 8g, with an emission ratio of < 0.4. This result was further improved when the authors used NaClO pre-treated HeLa cells. They were able to increase the ratio 
up to 0.85 (Figure 8l). This nanosystem was also used to detect ClO− in an in vivo model of arthritis. This result is illustrated in 
Figure 8m-o that shows the spatial distribution of the mission ratio generated by UC nanoparticles injected into the two limbs. 
Note that the left limb, subjected to an arthritis artificial induction, displayed a larger emission ratio than the health (control) right 
limb. 
Finally, we must emphasize that CS engineering is being used nowadays in many different ways to develop advanced biological 
labelling techniques. For instance, Chen et al.92 have reported CS RENPs capable of highly-sensitive multiplexed biomolecule 
detection by Z-contrast imaging. They have designed an encoding system based on different structures of UC CS RENPs, which 
present different contrast in each shell depending on the atomic number of the RE doped in that shell when viewed under scanning 
transmission electron microscopy. For this reason, we must expect a great deal of interest in the use of CS RENPs for biological 
labelling applying diverse techniques. 
E. CORE-SHELL RARE-EARTH-DOPED NANOPARTICLES FOR THERAPY 
In previous sections the application of CS RENPs for advanced bioimaging and biosensing has been described in detail. The 
breakthroughs achieved in these fields can be considered as advances in the diagnosis, as the information provided by CS RENPs 
can be used to detect, in early stages, diseases and biological malfunctions. In this fifth section we go further and provide a general 
review of the latest experimental works demonstrating the potential use of CS RENPs as therapeutic agents. In subsection E.1 we 
describe how CS RENPs have been used as triggering units for therapies based on fully controlled drug delivery. Subsection E.2 
describes how CS RENPs can be used to develop photoactivation therapies. Finally, in strong relation with subsection D.1, 
subsection E.3 is devoted to provide a general review of the use of CS RENPs for the development of fully controllable photothermal 
therapies of cancer tumours. 
E.1. Core-shell rare-earth-doped nanoparticles for drug delivery. 
The use of drug delivery nanosystems has increased enormously due to their enhanced therapeutic efficacy and reduced side 
effects, derived from their capacity to accurately target the specific area to be treated. Phototriggered-controlled drug-release 
devices (PDDs) have attracted great attention as they can be activated by light to obtain on-demand release. Light activation allows 
better spatial and temporal control of drug administration.93-96 PDDs are based on the encapsulation/linkage of drug molecules 
inside/to a photoreactive structure which can be “open” by the action of light in order to release the drug molecules when and 
where needed. Traditional PDDs require UV light for activation. This radiation induces phototoxicity and it shows a limited 
penetration depth into tissues. Due to these limitations, NIR light activated PDDs are receiving increasing attention in the biological 
context, since NIR light is able to penetrate deeper into tissue while creating less biological damage. One approach to achieve NIR 
phototriggered drug release is through the use of NIR-to-UV UC RENPs.88, 97-100 The design of UC RENP-based PDDs involves the 
combination of UC RENPs with a drug releaser unit into a single structure. It is in this step where the CS engineering has emerged 
as a smart solution by using a core constituted by an UC RENP surrounded by a shell that will act as drug releaser.94, 97, 99-102 When 
revisiting the literature, β-phase NaYF4:RE@NaYF4 systems emerge as the most popular for constituting the emitting core due to 
its high IR-to-UV-VIS optical conversion efficiency. 12 Regarding the drug releaser shell, there are two main strategies. The first one 
consists on the encapsulation of the UC core into a silica coating (UC RENP@SiO2) or into a polymer (UC RENP@polymer).  
  
SiO2 encapsulation is commonly used since its surface can be easily functionalized with diverse groups enabling other NPs or 
photosensitive molecules to attach. Moreover, mesoporous SiO2 (mSiO2) presents a porous structure (with high surface area), 
which provides reservoirs for loading drug molecules. By combining CS UCNPs with SiO2 or mSiO2 outer shells, novel CS 
nanomaterials for PDDs were obtained.98, 100, 103 Liu et al.98 reported a strategy for NIR-activated PDDs based on mSiO2-coated UC 
CS RENPs structure capable of simultaneously emit UV and VIS light. The anticancer drug Doxorubicin (DOX) was loaded into the 
mesoporous silica shell in addition to photoactive azobencene (azo) molecules. These photoresponsive molecules possess the 
ability to transit from the cis to trans isomer (and vice versa) by the absorption of VIS (or UV) light. The reversible photo 
isomerization by simultaneous UV and VIS light emitted by the UCNPs creates a continuous rotation-inversion movement of the 
azo molecules, which acts as a molecular impeller that drives the release of DOX molecules. The authors also demonstrated an in 
vitro controlled NIR-triggered drug delivery experiment. 
A similar approach was followed by He et al.,100 who developed a PDD based on a photosensitive ruthenium complex, which was 
used to shield the mSiO2 pores where DOX molecules were stored. They designed the UCNP@mSiO2 structure in order to maximize 
the UV emission, which overlaps with the absorption of the photosensitive complex. When activated, the Ru complexes act as 
molecular valves which allow the release of the drug molecules. Thanks to the developed PDD, these authors reported the lowest 
laser excitation power density at 980 nm ever used for UC RENP-assisted drug delivery (0.35 Wcm-2), which minimizes the 
overheating effect and photodamage produced by that wavelength. 
In the case of UCNP@polymer structures, UC CS RENPs organic polymers are employed as outer coating in order to load or link the 
drugs to the nanocarrier by means of self-assembly. Commonly used polymers are PEG, TWEEN, and PEI, among others.93, 102, 104 
Recently, Deng et al.102 designed, synthetized, and tested a novel aptamer-guided nanocarrier based on an UC RENP@polymer 
able to simultaneously perform targeted pH-triggered drug delivery and bioimaging. Another example is the multifunctional drug 
delivery system developed by Dai et al.104 which combines UC luminescence, MRI, and CT multimodal bioimaging with NIR-
activated platinum drug delivery, taking advantage of CS engineering. They applied the developed nanostructure to inhibit the 
growth of cancer tumours in animal models by using 980 nm radiation and the subsequent drug release. This multifunctional 
system can furthermore provide complete information to guide the cancer treatment since it can act as contrast agent for diverse 
imaging techniques. 
In addition to the two architectures described above, CS structures based on UC RENPs can be used to produce rattle-type (denoted 
as yolk–shell, YS) nanocarriers, as those shown in Figure 9). YSs are a special class of CS nanostructures with core@void@shell 
structure and tunable functionalities in both the cores and the hollow shell.101, 105-108 In this case, it is important to mention that 
core and shell units are not in physical contact. For the purpose 
of drug delivery, the main advantage of YS CSNPs is that the 
hollow cavity can endow the overall structure with a huge 
loading capacity. Zhang et al.101 synthetized a multifunctional 
YS structure consisting in a UC RENPs shell with a SiO2-coated 
Fe3O4 core. This structure emits VIS luminescence upon NIR 
excitation, and it can be manipulated using an external 
magnetic field to localize it at a specific target, at the same 
time, it can be used as UC imaging agent. Moreover, they 
demonstrated the usefulness of the YS structure as anticancer 
PDDs by loading the structure with DOX. Zhang et al.101 
demonstrated antitumour action in animal models by 
enhancing tumour targeting by the application of a magnetic 
field. 
Another interesting study was performed by Zhao et al.94. In 
this case, as it is shown in Figure 9a, the ACCh pro-drug is 
encapsulated inside a SiO2 sphere that shells a single UCP that 
acts as the yolk. Figure 9c shows a TEM image of the structures. 
Under 980 nm excitation, the UV emission produced by Tm3+ 
ions in the UCNP effectively activate the photolysis of the pro-
drug (Figure 9b) that leads to the release of the anticancer drug 
(ACCh) which diffuses out of the YS UC RENPs through the 
pores of the silica shell. The tumour growth and mouse survival 
rates were monitored after the treatment with the developed 
PDD. PDD-treated tumours showed a much slower growth rate 
in comparison with the control group (treated with saline and 
YS structure without Tm3+ ions as activators), as shown in 
  
Figure 9d. In addition, the survival time of mice after the administration of the YS UCNP-ACCh PDD was drastically prolonged, 
indicating the efficiency of the treatment. 
E.2. Core-shell rare-earth-doped nanoparticles for photoactivation therapies. 
The discovery of PDDs capabilities set off a new research line aiming the development of a new group of therapies: the so-called 
photoactivation (PAC) based therapies. Here PAC refers to the phenomenon by which molecules (sensitizers) are activated through 
the absorption of light. Then, these activated molecules can either produce or trigger the production of chemical species which 
have an effect on biological systems. The main difference between PAC-based systems and PDDs is that, in the first case, the 
activated molecule has the therapeutic effect itself while, in the second, the sensitizer is used to release the chemical species that 
has the therapeutic functionality. 
In analogy with the systems discussed in Section E.1, the sensitizers used in PAC-based systems are traditionally activated with UV 
or VIS radiation. Thus the use of optical systems capable of NIR-to-UV/VIS conversion is desirable in order to avoid the drawbacks 
of UV/VIS excitation. As in previous sections, a nice solution is the use an UC RENP as core/emitting unit.109 For the activation of 
the sensitizer, energy must be transferred between the UC RENPs and the molecules. Energy transfer between the UC RENP (donor) 
and the sensitizer (acceptor) is only possible if the emission band of the former overlaps with the absorption band(s) of the target 
molecule (as exemplified in the graphs of Figure 10a). Moreover, the efficiency of this energy transfer decreases as the distance 
between the donor and the acceptor increases, thus the separation between them must be minimized.110 Even when activation of 
endogenous sensitizers can be performed,111, 112 the best strategy to ensure good energy transfer is to coat the UC RENP with the 
target molecules, embedding them in an outer mesoporous shell, or encapsulating them inside a rattle or YS structure. Li et al.113 
demonstrated the possibility of producing core-multishell RENPs which can be excited by two different wavelengths leading to 
double emission band that, in turn, can separately be employed for the activation of distinct molecules (see Figure 10a). The blue 
emission of Tm3+ ions, obtained under 980 nm excitation, produced the structural transformation of azo molecules. At the same 
time, the green emission from Er3+ ions, obtained under 796 nm excitation, triggered the activation of rose bengal sensitizer. This 
proof of concept opens the possibility of developing advanced treatments which combine different therapies. In this case, azo 
molecules act as impellers for drug delivery in chemotherapy treatments, as explained in section E.1. In addition, rose bengal can 
be used for photodynamic therapies, as explained later on in this section. In addition, since the activation of the molecule only 
occurs at short range, highly localized therapies can be developed.114 Special care must be taken when designing the composition 
and thickness of the different layers. The interlayer thickness, usually employed for UC efficiency enhancement, must not 
compromise the energy transfer efficiency due to the increase in the distance between the emitting ions and the sensitizer, 
therefore a compromise must be found.115, 116 Ding et al.116 theoretically and experimentally demonstrated that an optimization 
of the energy transfer between the UC RENP and the sensitizer can be achieved by the proper shell thickness. 
As a special case of relevance within the field of PAC-assisted therapy, photodynamic therapy (PDT) should be commented in detail. 
PDT is based on the use of two, in principle, non-toxic agents (i.e. light and sensitizer, such as porphyrin compounds or titania) 
that, when combined, can produce deleterious effects in cells and tissues.117 In PDT, the sensitizer, after its light activation, 
transfers energy to molecular oxygen naturally present in the tissue to generate reactive oxygen species, such as singlet oxygen 
and, by continuation, radicals, which damage the cells. Recently published works have evidenced the superior in vitro PDT 
performance of CS structures.118 Among the different CS structures used for PDT, those involving UC cores emerged as the most 
promising one for both in vitro106, 111, 113, 119, 120 and in vivo121-123. As in previous cases, this is so because of the possibility of activating 
them with NIR light. In this sense, the work reported by Hou et al.121 should be highlighted. They developed dual sensitizer core-
multishell RENPs. In this structure the core was constituted by an UC RENP and it was in charge of NIR-to-VIS conversion. The 
closest shell was designed as a spacer between the UC core and the outset shell (containing the sensitizers). This spacing shell was 
introduced in the structure in order to enhance both the UC efficiency and the energy transfer from the emitting core and the 
sensitizer. The benefits of this spacing shell were demonstrated by the authors through achieving efficient in vivo treatment of 
tumours by PDT.  
  
Other photochemo-therapies have been developed based on 
the selective photo-activation of certain molecules also 
employing CS UC RENPs.123 For example, carbon monoxide is 
produced by cells which possess cytoprotective and anti-
inflammatory properties. Photoactivated carbon monoxide 
precursors, termed as photoCORM, have been developed in 
combination with CS UC RENPs for different therapeutic 
applications.124, 125 PAC of anticancer metal complexes by CS UC 
RENPs was also demonstrated.126 
Finally, PAC can also be used to influence or control intracellular 
structures, processes, and molecules. CS structures have indeed 
been used as activating agents in optogenetics experiments. 
These are based on the ability of light to control signal 
transmission and generation processes in neurons. Traditionally, 
the performances of optogenetics experiments require the 
incorporation of light-gated ion channels proteins (opsins) into 
neurons. Cellular signalling can then be activated or supressed 
through the selectivity opening or closing of these channels by 
using light. Pliss et al.114 demonstrated efficient control of 
optogenetic protein channels embedded in the cell membranes 
by employing the blue light generated by internalized CS UC 
RENPs after excitation with 975 nm radiation (see Figure 10b). 
They also observed that PAC only occurred in the vicinity of the 
CS UC RENPs, thus higher spatial precision was achieved when 
using the CS UC RENPs in comparison with direct blue light 
excitation of the channels. 
E.3. Core-shell rare earth-doped nanoparticles for photothermal 
therapies 
Thermal therapies are based on the selective heating of cancer cells or pathogenic tissues until they suffer irreversible damage, 
i.e. due to the advent of hyperthermia.127-129 NP-assisted thermal therapies, such as magnetic hyperthermia or photothermal 
therapies (PTTs), consist in the use of NPs as local heaters. In particular, PTTs employ light-activated heating NPs, i.e. NPs capable 
of efficient light-to-heat conversion.130 Gold NPs, carbon-based particles, and a variety of organic molecules, among others, have 
been extensively studied as efficient photothermal agents.75, 130-132 Traditionally, core-only structures were employed but this is 
changing towards the use of CS structures as they have been demonstrated as key materials to improve the selectivity and control 
of PTTs. 
In a pioneer study, Zhu et al.51 combined the emission enhancement of the temperature-sensitive luminescent core due to an inert 
shell with an outer carbon shell acting as heating unit to build a self-monitored nanoheater (see Figure 11a). This system was tested 
in vivo showing good results in the application of localized heat for the reduction of subcutaneous tumours size, as it is shown in 
Figure 11b and 11c. However, the excitation at 980 nm (leading to non-selective heating due to tissue absorption) and the emission 
of the temperature-sensitive luminescent ions in the VIS range (both out of the biological windows) make the clinical use of this 
system unviable. Moreover, the need of different wavelengths for the excitation of the temperature-sensitive luminescent core 
and the heating shell adds an extra difficulty. 
Figure 10. (a) Dual sensitizer core-multishell platform. 796 nm excitation promotes 
green emission from Er3+ ions which matches the absorption of rose bengal for PDT 
(left diagram and graph), while after 980 nm excitation blue emission of Tm3+ ions is 
produced which matches azo absorption for its activation (right diagram and graph). 
Reproduced with permission from 113. Copyright 2016 Wiley-VCH Verlag GmbH & Co. 
(b) Photoactivation of a optogenetic protein channel by means of direct blue 
excitation (centre) and UC emission from core-shell UC nanoparticles internalized by 
the cell (right). Reproduced with permission from 114. Copyright 2017 American 
Chemical Society. 
  
In order to overcome the drawbacks presented by the former structures, an alternative self-monitored nanoheater based only on 
CS RENPs was proposed by Ximendes et al.60 The performance of the LaF3:Er,Yb@LaF3:Nd CS RENPs as self-monitored nanoheaters 
was compared with that of homogeneously doped LaF3:Er,Yb,Nd RENPs to prove the benefits of using a CS structure in PTTs. The 
highly doped shell acts as both an 808 nm excited sensitizer and as a nanoheating unit. Relevant light-to-heat conversion 
efficiencies at the core were achieved thanks to the high Nd3+ dopant levels that result in a large energy diffusion and cross 
relaxation processes that enhance the overall non-radiative decay probabilities. The core units (doped with Yb3+ and Er3+ ions) 
behave as a thermal sensing unit by using the emission generated by the Er3+ thermalized levels for remote temperature reading, 
as Figure 11d schematizes. In this particular structure, the optical activation of both heating and sensing units was, for the first 
time, obtained under single wavelength excitation. At this point it is important to mention that the CS structure was necessary in 
order to separate Er3+ from Nd3+ ions to avoid the quenching of the emission of the former, as shown in Figure 11e. At the same 
time, the CS structure also avoids the reduction of the pump-to-heat conversion of Nd3+ ions due to energy transfer to Er3+ ions 
(see Figure 11f). The potential application of this system for controlled PTTs was tested in an ex vivo experiment. Full thermal 
control during a single beam PTT procedure was demonstrated by Ximendes et al. who, at the same time, claimed that further 
transfer into in vivo applications would require the use of sensing ions different from the VIS-emitting Er3+ ions in order to achieve 
larger penetration depths into tissues. 
A similar system was proposed by Tong et al. 133 employing Sm3+ ions as heating centres. As in the structure developed by Ximendes 
et al., the heating agent is placed in the core and the thermal sensitive Er3+ ions are allocated at the shell. Tong and co-workers 
also demonstrated the potential of these CS structures for fully controlled PTT, but with the limitation of using an excitation 
wavelength lying outside of the biological windows. 
The transfer to clinic of the above mentioned examples of CS RENPs is limited due to the poor penetration depth of the VIS Er3+ 
emission into tissues. This problem can be partially overcome by shifting the excitation wavelengths to the biological windows of 
transparency.58 A further and effective improvement would consist in increasing the net absorption of the excitation radiation, 
which could lead to a larger pump-to-heat conversion and to an increment in the total Er3+ emission intensity. This possible solution 
was explored by Shao et al.134 through the sensitization of the NaYF4:Yb,Er@NaYF4:Yb,Nd@dye CS RENPs by means of NIR 
absorbing dye molecules (the so-called IR-806). These molecules efficiently absorb 808 nm excitation and their emission overlaps 
  
with the absorption band of Nd3+ ions. So that the RE ions are excited thanks to dye-to-neodymium energy transfer. Shao and co-
workers demonstrated how CS NPs functionalized with these dye molecules shows a 28-fold enhancement in Er3+ emission 
intensity and about triple induced temperature rise.134 As stated in Section C.2, dye-sensitizing strategy is leading to relevant and 
numerous advances in several fields of application of RE-doped luminescent materials. 
In addition to the solution proposed by Shao et al., an interesting alternative solution was later demonstrated by Ximendes et al.135 
As explained in section D, they designed and developed LaF3:Yb@LaF3:Nd CS RENPs. In this case, the heating ions (Nd3+) were 
placed at the shell and the thermal reading was achieved by monitoring the temperature-dependent Nd3+→Yb3+ energy transfer 
in the CS interface. The excitation and the emission of this self-monitored nanoheater in the first and second biological windows 
of transparency, respectively, allowed to study real time ex vivo subcutaneous heating process, obtaining good estimations for the 
depth of the self-monitored nanoheaters and proving their potential application in in vivo controlled PTT. 
Taking another step forward in the control of PTTs, Marciniak et al.136 proposed CS RENPs as self-monitored nanoheaters, which 
uses Nd3+ ions not only as heating agents (stoichiometric core), but also as temperature sensors and imaging source (slightly doped 
outer shell). The non-doped interlayer avoids cross-relaxations between Nd3+ ions, increasing the quantum efficiency of the 
system. These authors suggested an excitation strategy to accurately select the volume of tissue to be treated and so avoid 
collateral damages, as NPs may distribute in specimens further from the zones to be treated. This is based on combining two laser 
beams with intensity lower than that of the threshold for producing hyperthermia, which overlap in the treated zone achieving a 
total intensity enough to rise temperature at the typical values of PTTs. 
F. CONCLUSIONS AND PERSPECTIVES 
In summary, we have examined the diverse CS RENPs that have already been used for biomedical purposes. This review article 
demonstrates that, although a lot of work has been done, this research field is, in our opinion, writing its first pages. The fast 
development of this area is clearly a consequence of the improvement in the techniques for synthesis that allowed the fabrication 
of high quality CS structures. Examples provided herein evidence that almost any imaginable structure can be synthetized. 
Among the different achievements described in this review, we think that three of them will have a great impact in the field of 
nanomedicine. The first one is the use of CS architectures in combination with dopant engineering to minimize undesirable thermal 
loading produced by the excitation source during imaging or sensing experiments. In this sense, neodymium ion is the most 
promising ion capable of efficient absorption at around 800 nm, where tissue absorption is minimum and the most cost-effective 
laser diodes work. Secondly, CS structures also made an old dream possible: the fabrication of a single system capable of 
simultaneous heating and thermal sensing. This allowed the development of minimally invasive thermal therapies activated either 
by light or by alternating magnetic fields. Finally, this review discussed how CS RENPs are starting to be used for in vivo studies 
aimed to alter the behaviour through the control of the brain. These last results demonstrated that the area of application of CS 
RENPs is not restricted to imaging or therapy but, indeed, these structures may become an indispensable and flexible tool for 
researchers working in the frontiers of knowledge. 
We have shown that CS RENPs have been widely used for photo-activated therapies based on drug release or drug activation. In 
most cases, UC RENPs that transform IR light into VIS or UV radiation (the latter being used as activating energy source) are 
employed. Despite the good results obtained so far in this area we are of the opinion that further optimization is still required. In 
particular, the quantum efficiency of UC processes in RENPs is typically very low (below 1%) so that the overall efficiency of the 
structures based on them is limited. In addition, CS RENPs have also the inherent drawback of the low absorption cross section 
characteristic of these ions (several orders of magnitude lower than those of quantum dots, for instance). Overcoming these 
limitations will be one of the challenges that the scientific community should face in the near future. Possible solutions could be 
found by exploring the synthesis of heavily doped structures with reduced quenching. This could be achieved by avoiding, for 
instance, cross relaxation and energy migration processes. 
CS RENPs have also been demonstrated to be promising probes for multimodal bioimaging. An adequate design has made possible 
the simultaneous acquisition of in vivo images by using different techniques such as X-Ray, luminescence, and MRI. The results 
obtained in this field are interesting and very attractive from a fundamental point of view. Nevertheless, in our opinion the actual 
advantage of obtaining simultaneous multimodal bioimages is not yet clearly demonstrated. We believe that some examples 
showing the positive synergy between these techniques should be given to convince the scientific community that the research 
on multimodal structures is worth the effort. For instance, we believe that these multimodal structures should be used for 
advanced and precise diagnosis in the near future to demonstrate that this research line is not just a fleeting fashion. 
In addition, CS engineering has demonstrated to be a very efficient strategy for tailoring the fluorescence lifetime of CS RENPs. In 
our opinion, this possibility offers more than just the development of high brightness structures (useful for the achievement of 
  
high contrast in vivo images). We are firmly convinced that lifetime tailoring will allow the use of such structures in advanced 
imaging based on time-domain analysis. 
Finally we would like to remark that the future use of CS RENPs for in vivo studies mainly relies on the development of 
nanostructures emitting within the second biological window of transparency of tissues (emissions in the 1000-1350 nm range). 
Therefore, we state that new combinations of RE ions should be explored to find a new nanostructures which presents intense 
and sensitive emission in this range under 800 nm excitation (fist biological window). Although some CS RENPs satisfying these 
requirements have already been presented (see Section D1), their brightness and efficiency are far from being high enough to 
ensure a successful transfer to the clinic. We also reckon that, in the near future, most of the commercial small animal imaging 
apparatuses will be equipped with broad band IR LED source instead of narrow-line laser diodes. This would boost the use of CS 
RENPs with broad absorption bands in the IR region. Therefore, we think that both inhomogeneous line broadened RE-doped 
systems and dye-sensitized RENPs could emerge with great potential. 
To conclude, CS RENPs are, without any doubt, promising systems for advanced diagnosis and therapy applications. Nevertheless, 
this research area is still in an early stage, since, for example, overcoming the challenge of moving into the clinic will require an 
intense work in complementary areas such as material sciences, optical engineering, and nanobiology. 
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